Effect of teprotumumab on intraocular pressure in thyroid-associated ophthalmopathy

PURPOSE: To examine changes in intraocular pressure (IOP) in patients with thyroid eye disease (TED) following teprotumumab. MATERIALS AND METHODS: A retrospective review of 17 patients with TED who received teprotumumab between January 2020 and September 2021 was conducted. IOP, extent of proptosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Adetunji, Modupe O., Nguyen, Brian J., McGeehan, Brendan, Tamhankar, Madhura A., Briceño, César A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558482/
https://www.ncbi.nlm.nih.gov/pubmed/36248076
http://dx.doi.org/10.4103/tjo.tjo_30_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558482/
https://www.ncbi.nlm.nih.gov/pubmed/36248076
http://dx.doi.org/10.4103/tjo.tjo_30_22

Ejemplares similares